Skip to main navigation Skip to search Skip to main content

Taming Postoperative Delirium with Dexmedetomidine: A Review of the Therapeutic Agent’s Neuroprotective Effects following Surgery

  • Stony Brook University

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations

Abstract

Postoperative delirium (POD) represents a perioperative neurocognitive disorder that has dreaded ramifications on a patient’s recovery from surgery. Dexmedetomidine displays multiple mechanisms of neuroprotection to assist in preventing POD as a part of a comprehensive anesthetic care plan. This review will cover dexmedetomidine’s pharmacological overlap with the current etiological theories behind POD along with pre-clinical and clinical studies on POD prevention with dexmedetomidine. While the body of evidence surrounding the use of dexmedetomidine for POD prevention still requires further development, promising evidence exists for the use of dexmedetomidine in select dosing and circumstances to enhance recovery from surgery.

Original languageEnglish
Article number1453
JournalPharmaceuticals
Volume16
Issue number10
DOIs
StatePublished - Oct 2023

Keywords

  • dexmedetomidine
  • neuroprotection
  • perioperative neurocognitive disorder
  • postoperative delirium

Fingerprint

Dive into the research topics of 'Taming Postoperative Delirium with Dexmedetomidine: A Review of the Therapeutic Agent’s Neuroprotective Effects following Surgery'. Together they form a unique fingerprint.

Cite this